Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus (Q36611056)

15 August 2017

1 reference

title

Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

15 August 2017

0 references

author name string

Nancy E Lane

series ordinal

1

1 reference

15 August 2017

1 October 2006

1 reference

Nature Clinical Practice Rheumatology

15 August 2017

1 reference

15 August 2017

2

1 reference

15 August 2017

10

1 reference

15 August 2017

562-569

1 reference

Bone mineral density in systemic lupus erythematosus and its relation to age at disease onset, plasmatic estradiol and immunosuppressive therapy

15 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Prevalence and predictors of fragility fractures in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Bone health and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

SLE, atherosclerosis and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Atherosclerosis in patients with autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Osteoporosis, inflammation and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Atherogenic high-fat diet reduces bone mineralization in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Homocysteine as a predictive factor for hip fracture in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Hyperhomocysteinemia in patients with Behçet's disease: is it due to inflammation or therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

An update on glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Steroid-induced osteoporosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Bone histomorphometry in glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement ther

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Differences in hip quantitative computed tomography (QCT) measurements of bone mineral density and bone strength between glucocorticoid-treated and glucocorticoid-naive postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

The management of secondary osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

7 January 2021

Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

7 January 2021

Induction of T-cell activation by oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

7 January 2021

Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

7 January 2021

Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

7 January 2021

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

7 January 2021

Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

7 January 2021

New developments in the pathogenesis and treatment of steroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0298

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0298

1 reference

15 August 2017

1 reference

PubMed ID

17016482